Top-News

Grail Aktie News

Aktie
WKN:  A40F8M ISIN:  US3847471014 US-Symbol:  GRAL Land:  USA
100,09 $
-4,615 $
-4,41%
85,978 € 21:05:02 Uhr
Depot/Watchlist
Marktkapitalisierung *
2,47 Mrd. €
Streubesitz
17,25%
KGV
-0,28
Index-Zuordnung
-

Grail News

18.06.25 - PR Newswire
GRAIL Announces Positive Top-Line Results From The Galleri® PATHFINDER 2 Registrational Study
GRAIL Announces Positive Top-Line Results From The Galleri® PATHFINDER 2 Registrational Study PR Newswire
30.05.25 - PR Newswire
GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) PR Newswire
21.05.25 - PR Newswire
GRAIL to Present at Jefferies Global Healthcare Conference 2025
GRAIL to Present at Jefferies Global Healthcare Conference 2025 PR Newswire
13.05.25 - PR Newswire
GRAIL Reports First Quarter 2025 Financial Results
GRAIL Reports First Quarter 2025 Financial Results PR Newswire
12.05.25 - PR Newswire
GRAIL and athenahealth Team Up to Offer Healthcare Providers Streamlined Ordering of GRAIL's Galleri® Multi-Cancer Early Detection (MCED) Test
GRAIL and athenahealth Team Up to Offer Healthcare Providers Streamlined Ordering of GRAIL's Galleri® Multi-​Cancer Early Detection (MCED) Test PR Newswire
11.05.25 - wallstreetONLINE Redaktion
"BYD ist besser": Tesla: Investor zerlegt Bewertung – US-Pensionsfonds blockt neue Aktienkäufe!
Star-​Investor Bill Miller sieht das Markt-​Tief als durchschritten – und empfiehlt Amazon. Tesla dagegen hält er für überbewertet und warnt vor Musk. Ein US-​Pensionsfonds hat bereits ...
29.04.25 - PR Newswire
GRAIL to Announce First Quarter 2025 Financial Results
GRAIL to Announce First Quarter 2025 Financial Results PR Newswire
22.04.25 - PR Newswire
GRAIL to Present New Data on Galleri® and its Methylation Platform at American Association for Cancer Research (AACR) Annual Meeting
GRAIL to Present New Data on Galleri® and its Methylation Platform at American Association for Cancer Research (AACR) Annual Meeting PR Newswire
26.02.25 - PR Newswire
GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) PR Newswire
25.02.25 - PR Newswire
GRAIL Partners With Actress Kate Walsh for Generation Possible to Raise Awareness of Multi-Cancer Early Detection Testing
GRAIL Partners With Actress Kate Walsh for Generation Possible to Raise Awareness of Multi-​Cancer Early Detection Testing PR Newswire
21.02.25 - PR Newswire
GRAIL to Present at TD Cowen 45th Annual Health Care Conference
GRAIL to Present at TD Cowen 45th Annual Health Care Conference PR Newswire
20.02.25 - PR Newswire
GRAIL Reports Fourth Quarter and Full Year 2024 Financial Results
GRAIL Reports Fourth Quarter and Full Year 2024 Financial Results PR Newswire
19.02.25 - PR Newswire
Investors Eye Biotech Sector as Cancer Therapy Market Surges
Investors Eye Biotech Sector as Cancer Therapy Market Surges PR Newswire
12.02.25 - PR Newswire
GRAIL to Announce Fourth Quarter 2024 Financial Results
GRAIL to Announce Fourth Quarter 2024 Financial Results PR Newswire
13.01.25 - PR Newswire
Patient Reported Outcomes for GRAIL's Galleri® Multi-Cancer Early Detection Blood Test Published in Lancet Oncology
Patient Reported Outcomes for GRAIL's Galleri® Multi-​Cancer Early Detection Blood Test Published in Lancet Oncology PR Newswire
18.12.24 - PR Newswire
GRAIL to Present at the 43rd Annual J.P. Morgan Healthcare Conference
GRAIL to Present at the 43rd Annual J.P. Morgan Healthcare Conference PR Newswire

Newssuche

Videos

newspaper
10:20 Uhr +1,03%
Technical Trading: Gold Zukauf Chance
Gold Long Typ: Turbo Open End WKN: VC5S7W Hebel: 2 Laufzeit: OpenEnd Einstieg: Market ... Mehr »